Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide

Plasmablastic lymphoma (PBL) is a rare and aggressive hematological malignancy. PBL commonly occurs in immune incompetent patients, such as those with human immunodeficiency virus (HIV), post-transplant status, or immunosenescence. Given its rarity, there is no specific standard treatment for PBL. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lili, Song, Qi, Liu, Mengke, Wang, Yan, Yi, Hongmei, Qian, Ying, Xu, Pengpeng, Cheng, Shu, Wang, Chaofu, Wang, Li, Zhao, Weili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312258/
https://www.ncbi.nlm.nih.gov/pubmed/34322131
http://dx.doi.org/10.3389/fimmu.2021.702593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312258/
https://www.ncbi.nlm.nih.gov/pubmed/34322131
http://dx.doi.org/10.3389/fimmu.2021.702593

Ejemplares similares